Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

ABSTRACT: RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have advanced or recurrent lymphoma.

DISEASE(S): Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms

PROVIDER: 2005072 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR